Introducing the Short Naming Test for Alzheimer’s disease patients (SNT-AD) (notice n° 574737)
[ vue normale ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 02242cam a2200229 4500500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250121133508.0 |
| 041 ## - LANGUAGE CODE | |
| Language code of text/sound track or separate title | fre |
| 042 ## - AUTHENTICATION CODE | |
| Authentication code | dc |
| 100 10 - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Simoes Loureiro, Isabelle |
| Relator term | author |
| 245 00 - TITLE STATEMENT | |
| Title | Introducing the Short Naming Test for Alzheimer’s disease patients (SNT-AD) |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Date of publication, distribution, etc. | 2021.<br/> |
| 500 ## - GENERAL NOTE | |
| General note | 78 |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | Our research aimed to propose a quick-to-administer tool for screening naming disorders in Alzheimer's disease (AD). These difficulties appear from the early stage of AD. Our Short Naming Test for AD (SNT-AD) is a very quick investigation of individuals’ naming abilities and comprises 10 black and white pictures. We carried out two studies. In the first one, we administered the SNT-AD to 55 participants: 26 individuals at the early stage of AD (MMSE >20), and 29 elderly people without cognitive disorders, matched in age, gender, and socio-cultural level. The results show that the performances of the participants in the two groups differ significantly. In the second study, we compared the performances of a group with early AD and a control group, on the SNT-AD, the BARD ( batterie rapide de dénomination), and the ExaDé ( batterie d’examen des troubles en dénomination). The SNT-AD and the ExaDé significantly distinguished our groups, but not the BARD. Finally, we computed an ROC analysis for all the participants of study 1 and 2 ( n = 91). At the threshold of three errors, the sensitivity of the SNT-AD reaches 70.5 % and the specificity equals 91.4 %. In conclusion, the SNT-AD is a quick-to-administer tool, making it very suitable for clinical as well as experimental uses. Our results are encouraging and lead us to propose that this tool be used by front-line practitioners when screening for AD. |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Taverne, Mathilda |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Malou, Valentine |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Basaglia-Pappas, Sandrine |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Besin, Romane |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Invernizzi, Sandra |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Lefebvre, Laurent |
| Relator term | author |
| 786 0# - DATA SOURCE ENTRY | |
| Note | Revue de neuropsychologie | Volume 13 | 3 | 2021-10-05 | p. 214-222 | 2101-6739 |
| 856 41 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://shs.cairn.info/journal-revue-de-neuropsychologie-2021-3-page-214?lang=en&redirect-ssocas=7080">https://shs.cairn.info/journal-revue-de-neuropsychologie-2021-3-page-214?lang=en&redirect-ssocas=7080</a> |
Pas d'exemplaire disponible.
Réseaux sociaux